UCB Ventures
Corporate VC•Pre-Seed / Seed, Series A/B • Belgium
UCB Ventures is a €150 million strategic corporate venture fund. UCB is a global biopharmaceutical company focused on neurology and immunology disorders, driven by innovative science to enhance patient lives worldwide. We work closely and forge strong connections with patients, caregivers, health care professionals and other stakeholders who know the challenges of these diseases and where the unmet needs are found all too well.
Typical Investment
€100k-€1.5M
Funding Stage
Pre-Seed / Seed, Series A/B
Headquarters
Belgium